Ameriprise’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$224K Buy
14,962
+157
+1% +$2.29K ﹤0.01% 3843
2025
Q4
$197K Sell
14,805
-783
-5% -$11.4K ﹤0.01% 3931
2025
Q3
$246K Buy
15,588
+69
+0.4% +$1.14K ﹤0.01% 3854
2025
Q2
$234K Buy
15,519
+698
+5% +$10.2K ﹤0.01% 3774
2025
Q1
$223K Sell
14,821
-789
-5% -$11.7K ﹤0.01% 3759
2024
Q4
$225K Buy
15,610
+252
+2% +$4.5K ﹤0.01% 3827
2024
Q3
$300K Sell
15,358
-163
-1% -$2.95K ﹤0.01% 3644
2024
Q2
$266K Sell
15,521
-1,559
-9% -$28.8K ﹤0.01% 3623
2024
Q1
$287K Sell
17,080
-3,197
-16% -$48.5K ﹤0.01% 3599
2023
Q4
$367K Sell
20,277
-358
-2% -$6.51K ﹤0.01% 3559
2023
Q3
$350K Buy
20,635
+3,214
+18% +$46K ﹤0.01% 3535
2023
Q2
$209K Sell
17,421
-567
-3% -$7.74K ﹤0.01% 3720
2023
Q1
$234K Buy
17,988
+128
+0.7% +$2.1K ﹤0.01% 3680
2022
Q4
$264K Buy
+17,860
New +$195K ﹤0.01% 3631
2022
Q1
Sell
-38,147
Closed -$1.18M 3974
2021
Q4
$1.18M Buy
+38,147
New +$1.24M ﹤0.01% 3185

Other funds holding HCM

Ameriprise's HCM Position: Q1 2026 in Review

Ameriprise increased its HUTCHMED (HCM) stake by 1.1% in Q1 2026, buying an estimated $2.29K and bringing the position to 14,962 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #3843.

Ameriprise first reported a position in HCM in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.18M in Q4 2021. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.

  • Ameriprise held 14,962 shares of HUTCHMED worth $224K as of Q1 2026.
  • Ameriprise bought 157 HUTCHMED shares in Q1 2026, an estimated $2.29K.
  • HUTCHMED made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3843 holding.
  • Ameriprise first reported a position in HUTCHMED in Q4 2021 and has held it in 15 quarters since.
  • Ameriprise's HUTCHMED position peaked at $1.18M in Q4 2021.
  • 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.